Chemical Structures (Image 01)
The text appears to be a mixture of chemical formulas and molecular weights. It is not a useful description.*
Ganciclovir Injection, Powder, Lyophilized, For Solution
Product Images NDC 70436-089
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ganciclovir (NDC 70436-089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Image 02)
The text appears to be a graph or chart related to the progression of CMV retinitis over time. The x-axis is labeled as "Time From Start of Maintenance Therapy (Days)" and the y-axis is not clear due to the incomplete text provided. Without the full context of the graph, it is difficult to provide a more detailed description.*
Figure 2 (Image 03)
The text is describing a graph titled "ICM 1774: Time to Progression of CMV Retinitis". The graph shows the progression of CMV Retinitis over time, with the x-axis measuring the time (in days) from the start of maintenance therapy, and the y-axis not visible in the given text. The numerical values of 20, 60, 90, and 120 probably represent intervals (in days) on the x-axis.*
Figure 3 (Image 04)
The provided text is a graph titled "AVI034: Time to Progression of CMV Retinitis". The x-axis measures time in days starting from the beginning of maintenance therapy, with values ranging from 0 to 150. The y-axis is not labeled but has values ranging from 0 to 120%. The graph includes a line graph that shows data points at 30, 60, and 120 days.*
Principal Display Panel (Vial Label)
Description: Ganciclovir injection, USP (50 mg equivalent to 500 mg per vial), for intravenous infusion only. The package insert contains the usual dosage and precautions, and handling instructions due to its potent cytotoxic and potentially carcinogenic properties. The NDC number is 70436-089-55, and the product should be stored at controlled room temperature.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
